Startseite Medizin The use of preanalytical quality indicators: a Turkish preliminary survey study
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

The use of preanalytical quality indicators: a Turkish preliminary survey study

  • Bagnu Orhan ORCID logo EMAIL logo , Derya Sonmez , Hikmet Can Cubukcu ORCID logo , Oguzhan Zengi , Humeyra Ozturk Emre ORCID logo , Ipek Cinaroglu , Murat Keles ORCID logo , Alper Gumus und Cihan Coskun
Veröffentlicht/Copyright: 20. Oktober 2020

Abstract

Objectives

The utilization of reliable quality indicators (QIs) proven to be suitable for monitoring and improvement tools is one of the best choices to minimize of the risk of errors in all laboratory processes called as total testing process (TTP). In 2008, a Working Group “Laboratory Errors and Patient Safety” (WG-LEPS) established by International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) developed the Model of Quality Indicators (MQI) complying with requirements of the ISO 15189:2012 standard for laboratory accreditation. They have also been dealing with harmonizing the QIs in most laboratories worldwide since then. The present study was set out to investigate the frequency of using IFCC WG-LEPS’ pre-QIs by Turkish laboratories and to assess the conformity of them, by taking into account Turkey’s conditions.

Methods

A survey consisting nine questions was applied in 81 laboratories using SurveyMonkey.

Results

According to the survey results, most of the laboratories reported they have used pre-QIs in the quality standards of health prepared by Turkish Ministry of Health (MOH). A part of IFCC WG-LEPS’ pre-QIs were being utilized by more than 80% of the laboratories, the rest of which only used by 10% of laboratories.

Conclusions

The majority of the medical laboratories have been using the pre-QIs included in the guidelines of Quality Standards prepared by the MOH. The pre-QIs are partially compatible with IFCC WG-LEPS’ pre-QIs. The definitions of IFCC WG-LEPS’ pre-QIs may also be revised to make them more clear and understandable by IFCC WG-LEPS. The insufficiency of Health Information Management Systems (HIMS) limits the use of pre-QIs proposed by IFCC WG-LEPS. Finally, the education of relevant personnel about the use of HIMS and pre-QIs is very crucial to harmonize and to extend the use of IFCC WG-LEPS’ pre-QIs in Turkish medical biochemistry laboratories.


Corresponding author: Bagnu Orhan, Department of Medical Biochemistry, University of Health Sciences, Istanbul Training and Research Hospital, 34098, Istanbul, Turkey, Phone. +90 2124596355, Fax: +90 2126210533, E-mail:

  1. Research funding: None declared.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

    This study was presented as an oral presentation in XXVIIth Balkan Clinical Laboratory Federation Meeting BCLF 2019-XXX. National Congress of the Turkish Biochemical Society TBS 2019.

References

1. Sciacovelli, L, Panteghini, M, Lippi, G, Sumarac, Z, Cadamuro, J, Galoro, CAO, et al. Defining a roadmap for harmonizing quality indicators in laboratory medicine: a consensus statement on behalf of the IFCC Working Group “Laboratory Error and Patient Safety” and EFLM Task and Finish Group “performance specifications for the extra-analytical phases”. Clin Chem Lab Med 2017;55:1478–88. https://doi.org/10.1515/cclm-2017-0412.Suche in Google Scholar PubMed

2. Sciacovelli, L, Lippi, G, Sumarac, Z, West, J, Garcia Del Pino Castro, I, Furtado Vieira, K, et al. Quality indicators in laboratory medicine: the status of the progress of IFCC Working Group “Laboratory Errors And Patient Safety” project. Clin Chem Lab Med 2017;55:348–57. https://doi.org/10.1515/cclm-2016-0929.Suche in Google Scholar PubMed

3. Plebani, M. Errors in laboratory medicine and patient safety: the road ahead. Clin Chem Lab Med 2007;45:700–7. https://doi.org/10.1515/cclm.2007.170.Suche in Google Scholar

4. Plebani, M, Astion, ML, Barth, JH, Chen, W, de Oliveira Galoro, CA, Escuer, MI, et al. Harmonization of quality indicators in laboratory medicine. A preliminary consensus. Clin Chem Lab Med 2014;52:951–8. https://doi.org/10.1515/cclm-2014-0142.Suche in Google Scholar PubMed

5. Sciacovelli, L, Plebani, M. The IFCC Working Group on laboratory errors and patient safety. Clin Chim Acta 2009;404:79–85. https://doi.org/10.1016/j.cca.2009.03.025.Suche in Google Scholar PubMed

6. International Organization for Standardization. ISO 15189:2012: medical laboratories: particular requirements for quality and competence. Geneva, Switzerland: International Organization for Standardization; 2012.Suche in Google Scholar

7. Plebani, M, Sciacovelli, L, Aita, A, Padoan, A, Chiozza, M. Quality indicators to detect pre-analytical errors in laboratory testing. Clin Chim Acta 2014;432:44–8. https://doi.org/10.1016/j.cca.2013.07.033.Suche in Google Scholar PubMed

8. Plebani, M. Quality indicators to detect pre-analytical errors in laboratory testing. Clin Biochem Rev 2012;33:85–8. PMID: 22930602, PMCID: PMC3428256.10.1016/j.cca.2013.07.033Suche in Google Scholar

9. Sciacovelli, L, Sonntag, O, Padoan, A, Zambon, CF, Carraro, P, Plebani, M. Monitoring quality indicators in laboratory medicine does not automatically result in quality improvement. Clin Chem Lab Med 2011;50:463–9. https://doi.org/10.1515/CCLM.2011.809.Suche in Google Scholar PubMed

10. WG-LEPS quality indicators in laboratory medicine. Available from: http://217.148.121.44/MqiWeb/Page_QualityIndicators.jsf [Accessed 7 Mar 2019].Suche in Google Scholar

11. Ministry of Health Quality Standards in Health. Available from: https://dosyamerkez.saglik.gov.tr/Eklenti/3460,skshastanesetiv5r1pdf.pdf?0. [Accessed 22 Oct 2019].Suche in Google Scholar

12. IFCC Working Group-Laboratory Errors And Patient Safety (WG-LEPS) quality indicators projects. Available from: http://www.ifcc.org/ifcc-education-division/working-groups-special-projects/laboratory-errors-and-patient-safety-wg-leps/quality-indicators-project/ [Accessed 6 Apr 2020].Suche in Google Scholar

13. Clinical and Laboratory Standards Institute (CLSI). Development and use of quality indicators for laboratory improvement, 2nd ed. CLSI guideline QMS12. Available from: https://clsi.org/standards/products/quality-management-systems/documents/qms12/.Suche in Google Scholar

14. Lukić, V. Laboratory information system–where are we today?. J Med Biochem 2017;36:220–4. https://doi.org/10.1515/jomb-2017-0021.Suche in Google Scholar PubMed PubMed Central

15. Plebani, M, Sciacovelli, L, Aita, A. Quality indicators for the total testing process. Clin Lab Med 2017;37:187–205. https://doi.org/10.1016/j.cll.2016.09.015.Suche in Google Scholar PubMed

16. Guideline for venous blood collection (phlebotomy). Prepared by the preanalytic phase Working Group of the Turkish Biochemical Society. Available from: https://www.eflm.eu/files/efcc/Venous%20Blood%20Collection%20-Turkish%20NS.pdf [Accessed 22 Oct 2019].Suche in Google Scholar

Received: 2020-09-21
Accepted: 2020-10-09
Published Online: 2020-10-20
Published in Print: 2021-04-27

© 2020 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Frontmatter
  2. Editorial
  3. Home pregnancy tests: quality first
  4. Review
  5. Non-invasive determination of uric acid in human saliva in the diagnosis of serious disorders
  6. Opinion Papers
  7. Basophil counting in hematology analyzers: time to discontinue?
  8. The role of laboratory hematology between technology and professionalism: the paradigm of basophil counting
  9. Recommendations for validation testing of home pregnancy tests (HPTs) in Europe
  10. General Clinical Chemistry and Laboratory Medicine
  11. The use of preanalytical quality indicators: a Turkish preliminary survey study
  12. The Italian External Quality Assessment (EQA) program on urinary sediment by microscopy examination: a 20 years journey
  13. Non-HDL-C/TG ratio indicates significant underestimation of calculated low-density lipoprotein cholesterol (LDL-C) better than TG level: a study on the reliability of mathematical formulas used for LDL-C estimation
  14. Evaluation of the protein gap for detection of abnormal serum gammaglobulin level: an imperfect predictor
  15. Impact of routine S100B protein assay on CT scan use in children with mild traumatic brain injury
  16. Using machine learning to develop an autoverification system in a clinical biochemistry laboratory
  17. Effect of collection matrix, platelet depletion, and storage conditions on plasma extracellular vesicles and extracellular vesicle-associated miRNAs measurements
  18. Pneumatic tube transportation of urine samples
  19. Evaluation of the first immunosuppressive drug assay available on a fully automated LC-MS/MS-based clinical analyzer suggests a new era in laboratory medicine
  20. A validated LC-MS/MS method for the simultaneous quantification of the novel combination antibiotic, ceftolozane–tazobactam, in plasma (total and unbound), CSF, urine and renal replacement therapy effluent: application to pilot pharmacokinetic studies
  21. Immunosuppressant quantification in intravenous microdialysate – towards novel quasi-continuous therapeutic drug monitoring in transplanted patients
  22. Reference Values and Biological Variations
  23. Reference intervals for venous blood gas measurement in adults
  24. Cardiovascular Diseases
  25. Detection and functional characterization of a novel MEF2A variation responsible for familial dilated cardiomyopathy
  26. Diabetes
  27. Evaluation of the ARKRAY HA-8190V instrument for HbA1c
  28. Infectious Diseases
  29. An original multiplex method to assess five different SARS-CoV-2 antibodies
  30. Evaluation of dried blood spots as alternative sampling material for serological detection of anti-SARS-CoV-2 antibodies using established ELISAs
  31. Variability of cycle threshold values in an external quality assessment scheme for detection of the SARS-CoV-2 virus genome by RT-PCR
  32. The vasoactive peptide MR-pro-adrenomedullin in COVID-19 patients: an observational study
  33. Corrigenda
  34. Corrigendum to: Understanding and managing interferences in clinical laboratory assays: the role of laboratory professionals
  35. Corrigendum to: Age appropriate reference intervals for eight kidney function and injury markers in infants, children and adolescents
  36. Letters to the Editor
  37. A panhaemocytometric approach to COVID-19: a retrospective study on the importance of monocyte and neutrophil population data on Sysmex XN-series analysers
  38. Letter in reply to the letter to the editor of Harte JV and Mykytiv V with the title “A panhaemocytometric approach to COVID-19: a retrospective study on the importance of monocyte and neutrophil population data”
  39. SARS-CoV-2 serologic tests: do not forget the good laboratory practice
  40. Long-term kinetics of anti-SARS-CoV-2 antibodies in a cohort of 197 hospitalized and non-hospitalized COVID-19 patients
  41. Self-sampling at home using volumetric absorptive microsampling: coupling analytical evaluation to volunteers’ perception in the context of a large scale study
  42. Vortex mixing to alleviate pseudothrombocytopenia in a blood specimen with platelet satellitism and platelet clumps
  43. Comparative evaluation of the fully automated HemosIL® AcuStar ADAMTS13 activity assay vs. ELISA: possible interference by autoantibodies different from anti ADAMTS-13
  44. Significant interference on specific point-of-care glucose measurements due to high dose of intravenous vitamin C therapy in critically ill patients
  45. As time goes by, on that you can rely preservation of urine samples for morphological analysis of erythrocytes and casts
  46. Stability of control materials for α-thalassemia immunochromatographic strip test
  47. Reformulated Architect® cyclosporine CMIA assay: improved imprecision, worse comparability between methods
  48. Urine-to-plasma contamination mimicking acute kidney injury: small drops with major consequences
  49. Automated Mindray CL-1200i chemiluminescent assays of renin and aldosterone for the diagnosis of primary aldosteronism
  50. Use of common reference intervals does not necessarily allow inter-method numerical result trending
  51. Reply to Dr Hawkins regarding comparability of results for monitoring
Heruntergeladen am 26.1.2026 von https://www.degruyterbrill.com/document/doi/10.1515/cclm-2020-1426/html
Button zum nach oben scrollen